Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Investigation of Tg-43 Dosimetric Parameters for 192 Ir Brachytherapy Source Using Gate Monte Carlo Code Publisher



Joya M1, 2 ; Nedaie HA1 ; Geraily G1 ; Rezaei H1, 3 ; Bromand A4 ; Ghorbani M5 ; Sheikhzadeh P1, 6
Authors

Source: Journal of Medical Physics Published:2023


Abstract

Purpose: According to the revised Task Group number 43 recommendations, a brachytherapy source must be validated against a similar or identical source before its clinical application. The purpose of this investigation is to verify the dosimetric data of the high dose rate (HDR) BEBIG 192 Ir source (Ir2.A85-2). Materials and Methods: The HDR 192 Ir encapsulated seed was simulated and its main dosimetric data were calculated using Geant4 Application for Tomographic Emission (GATE) simulation code. Cubic cells were used for the calculation of dose rate constant and radial dose function while for anisotropy function ring cells were used. DoseActors were simulated and attached to the respective cells to obtain the required data. Results: The dose rate constant was obtained as 1.098 ± 0.003 cGy.h - 1.U - 1, differing by 1.0% from the reference value reported by Granero et al. Similarly, the calculated values for radial dose and anisotropy functions presented good agreement with the results obtained by Granero et al. Conclusion: The results of this study suggest that the GATE Monte Carlo code is a valid toolkit for benchmarking brachytherapy sources and can be used for brachytherapy simulation-based studies and verification of brachytherapy treatment planning systems. © 2023 Wolters Kluwer Medknow Publications. All rights reserved.
Other Related Docs
18. 3D in Vivo Dosimetry of Hdr Gynecological Brachytherapy Using Micro Silica Bead Tlds, Journal of Applied Clinical Medical Physics (2022)
20. Evaluation of Mri-Based Magic Polymer Gel Dosimeter in Small Photon Fields, International Journal of Radiation Research (2021)